{"pmid":32283159,"title":"Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19.","text":["Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19.","J Infect","Liu, Zeming","Long, Wei","Tu, Mengqi","Chen, Sichao","Huang, Yihui","Wang, Shipei","Zhou, Wei","Chen, Danyang","Zhou, Ling","Wang, Min","Wu, Meng","Huang, Qi","Xu, Haibo","Zeng, Wen","Guo, Liang","32283159"],"journal":"J Infect","authors":["Liu, Zeming","Long, Wei","Tu, Mengqi","Chen, Sichao","Huang, Yihui","Wang, Shipei","Zhou, Wei","Chen, Danyang","Zhou, Ling","Wang, Min","Wu, Meng","Huang, Qi","Xu, Haibo","Zeng, Wen","Guo, Liang"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32283159","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jinf.2020.03.054","keywords":["CD4+","CD8+","COVID-19","Lymphocyte subset counts","SARS-CoV-2"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1663989232662740992,"score":7.979339,"similar":[{"pmid":32227123,"title":"Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia.","text":["Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia.","BACKGROUND: Since December 2019, novel coronavirus (SARS-CoV-2)-infected pneumonia (COVID-19) occurred in Wuhan, and rapidly spread throughout China. We aimed to clarify the characteristics and clinical significance of peripheral lymphocyte subset alteration in COVID-19. METHODS: The levels of peripheral lymphocyte subsets were measured by flow cytometry in 60 hospitalized COVID-19 patients before and after treatment, and their association with clinical characteristics and treatment efficacy was analyzed. RESULTS: Total lymphocytes, CD4+ T cells, CD8+ T cells, B cells and natural killer (NK) cells decreased in COVID-19 patients, and severe cases had a lower level than mild cases. The subsets showed a significant association with the inflammatory status in COVID-19, especially CD8+ T cells and CD4+/CD8+ ratio. After treatment, 37 patients (67%) reached clinical response, with an increase of CD8+ T cells and B cells. No significant change of any subset was detected in non-response cases. In multivariate analysis, post-treatment decrease of CD8+ T cells and B cells and increase of CD4+/CD8+ ratio were indicated as independent predictors for poor efficacy. CONCLUSIONS: Peripheral lymphocyte subset alteration was associated with the clinical characteristics and treatment efficacy of COVID-19. CD8+ T cells tended to be an independent predictor for COVID-19 severity and treatment efficacy.","J Infect Dis","Wang, Fan","Nie, Jiayan","Wang, Haizhou","Zhao, Qiu","Xiong, Yong","Deng, Liping","Song, Shihui","Ma, Zhiyong","Mo, Pingzheng","Zhang, Yongxi","32227123"],"abstract":["BACKGROUND: Since December 2019, novel coronavirus (SARS-CoV-2)-infected pneumonia (COVID-19) occurred in Wuhan, and rapidly spread throughout China. We aimed to clarify the characteristics and clinical significance of peripheral lymphocyte subset alteration in COVID-19. METHODS: The levels of peripheral lymphocyte subsets were measured by flow cytometry in 60 hospitalized COVID-19 patients before and after treatment, and their association with clinical characteristics and treatment efficacy was analyzed. RESULTS: Total lymphocytes, CD4+ T cells, CD8+ T cells, B cells and natural killer (NK) cells decreased in COVID-19 patients, and severe cases had a lower level than mild cases. The subsets showed a significant association with the inflammatory status in COVID-19, especially CD8+ T cells and CD4+/CD8+ ratio. After treatment, 37 patients (67%) reached clinical response, with an increase of CD8+ T cells and B cells. No significant change of any subset was detected in non-response cases. In multivariate analysis, post-treatment decrease of CD8+ T cells and B cells and increase of CD4+/CD8+ ratio were indicated as independent predictors for poor efficacy. CONCLUSIONS: Peripheral lymphocyte subset alteration was associated with the clinical characteristics and treatment efficacy of COVID-19. CD8+ T cells tended to be an independent predictor for COVID-19 severity and treatment efficacy."],"journal":"J Infect Dis","authors":["Wang, Fan","Nie, Jiayan","Wang, Haizhou","Zhao, Qiu","Xiong, Yong","Deng, Liping","Song, Shihui","Ma, Zhiyong","Mo, Pingzheng","Zhang, Yongxi"],"date":"2020-04-01T11:00:00Z","year":2020,"_id":"32227123","week":"202014|Mar 30 - Apr 05","doi":"10.1093/infdis/jiaa150","keywords":["COVID-19","lymphocyte subset","pneumonia"],"source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1663352135252705280,"score":97.91667},{"pmid":32114745,"title":"[Characteristics of peripheral blood leukocyte differential counts in patients with COVID-19].","text":["[Characteristics of peripheral blood leukocyte differential counts in patients with COVID-19].","To investigate the early changes of peripheral blood leukocyte differential counts in patients with COVID-19. Ten patients with COVID-19 and 30 patients with other viral pneumonia (non-COVID-19) admitted to Shanghai Jiao Tong University Affiliated Sixth People's Hospital and Jinshan Branch Hospital from January 22 to February 17, 2020 were enrolled in this study. The differential counts of white blood cells were analyzed. Patients in COVID-19 group showed relatively lower absolute white blood cell (WBC) count 4.95(3.90,6.03)x10(9)/L, lymphocyte absolute count 1.20(0.98,1.50)x10(9)/L and eosinophil absolute count 0.01(0.01,0.01)x10(9)/L. Leukopenia developed in two patients(2/10), lymphocytopenia also in two patients(2/10). Seven over ten patients presented with eosinophil cytopenia. In non-COVID-19 group, absolute WBC count was 8.20 (6.78,9.03) x10(9)/L (P<0.001), lymphocyte absolute count 1.75(1.20,2.53)x10(9)/L(P=0.036), eosinophil absolute count 0.02(0.01,0.03)x10(9)/L(P=0.05). Lymphocytopenia occurred in (16.7%) patients, eosinophil cytopenia in 16.7% patients too. In conclusion, leukopenia, lymphocytopenia and eosinophil cytopenia are more common in COVID-19 patients than those in non- COVID-19 patients.","Zhonghua Nei Ke Za Zhi","Li, Y X","Wu, W","Yang, T","Zhou, W","Fu, Y M","Feng, Q M","Ye, J M","32114745"],"abstract":["To investigate the early changes of peripheral blood leukocyte differential counts in patients with COVID-19. Ten patients with COVID-19 and 30 patients with other viral pneumonia (non-COVID-19) admitted to Shanghai Jiao Tong University Affiliated Sixth People's Hospital and Jinshan Branch Hospital from January 22 to February 17, 2020 were enrolled in this study. The differential counts of white blood cells were analyzed. Patients in COVID-19 group showed relatively lower absolute white blood cell (WBC) count 4.95(3.90,6.03)x10(9)/L, lymphocyte absolute count 1.20(0.98,1.50)x10(9)/L and eosinophil absolute count 0.01(0.01,0.01)x10(9)/L. Leukopenia developed in two patients(2/10), lymphocytopenia also in two patients(2/10). Seven over ten patients presented with eosinophil cytopenia. In non-COVID-19 group, absolute WBC count was 8.20 (6.78,9.03) x10(9)/L (P<0.001), lymphocyte absolute count 1.75(1.20,2.53)x10(9)/L(P=0.036), eosinophil absolute count 0.02(0.01,0.03)x10(9)/L(P=0.05). Lymphocytopenia occurred in (16.7%) patients, eosinophil cytopenia in 16.7% patients too. In conclusion, leukopenia, lymphocytopenia and eosinophil cytopenia are more common in COVID-19 patients than those in non- COVID-19 patients."],"journal":"Zhonghua Nei Ke Za Zhi","authors":["Li, Y X","Wu, W","Yang, T","Zhou, W","Fu, Y M","Feng, Q M","Ye, J M"],"date":"2020-03-03T11:00:00Z","year":2020,"_id":"32114745","week":"202010|Mar 02 - Mar 08","doi":"3760.10/cma.j.cn112138-20200221-00114","keywords":["COVID-19","Eosinophil","Viral pneumonia"],"source":"PubMed","locations":["lymphocytopenia"],"topics":["Diagnosis"],"weight":1,"_version_":1663352134348832769,"score":64.79026},{"pmid":32242950,"title":"Neutrophil-to-Lymphocyte ratio and Lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis.","text":["Neutrophil-to-Lymphocyte ratio and Lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis.","Since March 11, 2020, the World Health Organization (WHO) defined Coronavirus disease 2019 (COVID-19) as a pandemic, with a series of confirmed cases that currently exceeded 300,000 people worldwide and with approximately 14,500 deaths. Accumulated evidence suggests that a subgroup of patients with severe COVID-19 could have a dysregulation of the immune response that allows the development of viral hyperinflammation. Thus, all patients with severe COVID-19 should be screened for hyperinflammation using laboratory parameters in order to improve mortality. Neutrophil-to-Lymphocyte ratio (NLR) and Lymphocyte-to-C-reactive protein ratio (LCR) are established inflammation markers that reflect systemic inflammatory response, and both are available in almost all laboratories. In this study, a meta-analysis was performed to investigate whether NLR and LCR values can help predict clinical severity in patients with COVID-19. This article is protected by copyright. All rights reserved.","J Med Virol","Lagunas-Rangel, Francisco Alejandro","32242950"],"abstract":["Since March 11, 2020, the World Health Organization (WHO) defined Coronavirus disease 2019 (COVID-19) as a pandemic, with a series of confirmed cases that currently exceeded 300,000 people worldwide and with approximately 14,500 deaths. Accumulated evidence suggests that a subgroup of patients with severe COVID-19 could have a dysregulation of the immune response that allows the development of viral hyperinflammation. Thus, all patients with severe COVID-19 should be screened for hyperinflammation using laboratory parameters in order to improve mortality. Neutrophil-to-Lymphocyte ratio (NLR) and Lymphocyte-to-C-reactive protein ratio (LCR) are established inflammation markers that reflect systemic inflammatory response, and both are available in almost all laboratories. In this study, a meta-analysis was performed to investigate whether NLR and LCR values can help predict clinical severity in patients with COVID-19. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Lagunas-Rangel, Francisco Alejandro"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32242950","week":"202014|Mar 30 - Apr 05","doi":"10.1002/jmv.25819","keywords":["Inflammation","Lymphocyte","Neutrophil"],"source":"PubMed","locations":["Neutrophil"],"topics":["Diagnosis"],"weight":1,"_version_":1663352135741341696,"score":60.40819},{"pmid":32242348,"title":"Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19.","text":["Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19.","BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected pneumonia emerged in Wuhan, China in December 2019. In this retrospective multicenter study, we investigated the clinical course and outcomes of novel coronavirus disease 2019 (COVID-19) from early cases in Republic of Korea. METHODS: All of the cases confirmed by real time polymerase chain reaction were enrolled from the 1st to the 28th patient nationwide. Clinical data were collected and analyzed for changes in clinical severity including laboratory, radiological, and virologic dynamics during the progression of illness. RESULTS: The median age was 40 years (range, 20-73 years) and 15 (53.6%) patients were male. The most common symptoms were cough (28.6%) and sore throat (28.6%), followed by fever (25.0%). Diarrhea was not common (10.7%). Two patients had no symptoms. Initial chest X-ray (CXR) showed infiltration in 46.4% of the patients, but computed tomography scan confirmed pneumonia in 88.9% (16/18) of the patients. Six patients (21.4%) required supplemental oxygen therapy, but no one needed mechanical ventilation. Lymphopenia was more common in severe cases. Higher level of C-reactive protein and worsening of chest radiographic score was observed during the 5-7 day period after symptom onset. Viral shedding was high from day 1 of illness, especially from the upper respiratory tract (URT). CONCLUSION: The prodromal symptoms of COVID-19 were mild and most patients did not have limitations of daily activity. Viral shedding from URT was high from the prodromal phase. Radiological pneumonia was common from the early days of illness, but it was frequently not evident in simple CXR. These findings could be plausible explanations for the easy and rapid spread of SARS-CoV-2 in the community.","J Korean Med Sci","Kim, Eu Suk","Chin, Bum Sik","Kang, Chang Kyung","Kim, Nam Joong","Kang, Yu Min","Choi, Jae Phil","Oh, Dong Hyun","Kim, Jeong Han","Koh, Boram","Kim, Seong Eun","Yun, Na Ra","Lee, Jae Hoon","Kim, Jin Yong","Kim, Yeonjae","Bang, Ji Hwan","Song, Kyoung Ho","Kim, Hong Bin","Chung, Ki Hyun","Oh, Myoung Don","32242348"],"abstract":["BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected pneumonia emerged in Wuhan, China in December 2019. In this retrospective multicenter study, we investigated the clinical course and outcomes of novel coronavirus disease 2019 (COVID-19) from early cases in Republic of Korea. METHODS: All of the cases confirmed by real time polymerase chain reaction were enrolled from the 1st to the 28th patient nationwide. Clinical data were collected and analyzed for changes in clinical severity including laboratory, radiological, and virologic dynamics during the progression of illness. RESULTS: The median age was 40 years (range, 20-73 years) and 15 (53.6%) patients were male. The most common symptoms were cough (28.6%) and sore throat (28.6%), followed by fever (25.0%). Diarrhea was not common (10.7%). Two patients had no symptoms. Initial chest X-ray (CXR) showed infiltration in 46.4% of the patients, but computed tomography scan confirmed pneumonia in 88.9% (16/18) of the patients. Six patients (21.4%) required supplemental oxygen therapy, but no one needed mechanical ventilation. Lymphopenia was more common in severe cases. Higher level of C-reactive protein and worsening of chest radiographic score was observed during the 5-7 day period after symptom onset. Viral shedding was high from day 1 of illness, especially from the upper respiratory tract (URT). CONCLUSION: The prodromal symptoms of COVID-19 were mild and most patients did not have limitations of daily activity. Viral shedding from URT was high from the prodromal phase. Radiological pneumonia was common from the early days of illness, but it was frequently not evident in simple CXR. These findings could be plausible explanations for the easy and rapid spread of SARS-CoV-2 in the community."],"journal":"J Korean Med Sci","authors":["Kim, Eu Suk","Chin, Bum Sik","Kang, Chang Kyung","Kim, Nam Joong","Kang, Yu Min","Choi, Jae Phil","Oh, Dong Hyun","Kim, Jeong Han","Koh, Boram","Kim, Seong Eun","Yun, Na Ra","Lee, Jae Hoon","Kim, Jin Yong","Kim, Yeonjae","Bang, Ji Hwan","Song, Kyoung Ho","Kim, Hong Bin","Chung, Ki Hyun","Oh, Myoung Don"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32242348","week":"202014|Mar 30 - Apr 05","doi":"10.3346/jkms.2020.35.e142","keywords":["COVID-19","Cohort Study","Prognosis","Republic of Korea","SARS-CoV-2","Viral Pneumonia"],"source":"PubMed","locations":["Wuhan","China","South Korea"],"countries":["Korea, Republic of","China"],"countries_codes":["KOR|Korea, Republic of","CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1663352135724564481,"score":51.829384},{"pmid":32226636,"pmcid":"PMC7100419","title":"Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study.","text":["Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study.","Signal Transduct Target Ther","Tan, Li","Wang, Qi","Zhang, Duanyang","Ding, Jinya","Huang, Qianchuan","Tang, Yi-Quan","Wang, Qiongshu","Miao, Hongming","32226636"],"journal":"Signal Transduct Target Ther","authors":["Tan, Li","Wang, Qi","Zhang, Duanyang","Ding, Jinya","Huang, Qianchuan","Tang, Yi-Quan","Wang, Qiongshu","Miao, Hongming"],"date":"2020-04-01T11:00:00Z","year":2020,"_id":"32226636","week":"202014|Mar 30 - Apr 05","doi":"10.1038/s41392-020-0148-4","keywords":["Immunological disorders","Infectious diseases"],"source":"PubMed","topics":["Diagnosis","Mechanism","Treatment"],"weight":1,"_version_":1663352135307231233,"score":49.889114}]}